Espoo, Finland. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has signed a new commercial relationship with Cerba, world reference laboratory in specialized clinical pathology. As part of the collaboration, Euformatics delivers the full Genomics Hub software suite to Cerba to power their NGS test validation, continuous quality […]
The hospital is using the SOPHiA DDM™ Platform to advance the research of Homologous Recombination Repair Mutated Cancers BOSTON and ROLLE — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that CHU Bordeaux, a full-service hospital servicing the population of Bordeaux and the surrounding area, has completed implementation of […]
Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe. With the expanded relationship SOPHiA GENETICS will now further […]
The School of Medicine will use the SOPHiA DDM™ Platform to expand its hematologic testing program for blood cancers BOSTON and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Tulane University School of Medicine in New Orleans, Louisiana is live on SOPHiA GENETICS technology. […]
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Alex Ide as the company’s Executive Vice President (EVP) of Sales for the UK. In this pivotal role, Alex will be overseeing the customer-facing work underpinning the company’s commercial success through acquisition of new clients in a major market pioneering […]
Major software update enables biopharma R&D organizations to adopt innovative NGS-driven assays to confirm identity, integrity, potency, and safety throughout CGT product development and deploy them within a GMP-compliant environment Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®, the collaborative end-to-end […]
Complete collaborative environment with intuitive interface addresses common analysis challenges to help accelerate transition from scientific discovery to data-driven precision medicine MOUNTAIN VIEW, Calif., and LUGANO, Switzerland — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced a collaboration with BigOmics Analytics, a Swiss biomedical data […]
Comprehensive cloud platform provides industry-leading data quality, security, privacy, and compliance for ongoing service that screens for more than 300 inherited conditions with automated annual re-analysis MOUNTAIN VIEW, Calif., and LA JOLLA, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that Fore Genomics, […]
Platform strengthens Gilead’s Research’s data science capabilities to accelerate research pipeline of transformative therapies Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a licensing agreement with Gilead Sciences, Inc. to help the company leverage the power of multi-omics data in the discovery of life-changing therapeutics across multiple […]
MINNEAPOLIS, FOXO Technologies Inc.™ (NYSEAM: FOXO), a leader in the field of commercializing epigenetic biomarker technology, today announced the launch of its cutting-edge Bioinformatics Services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefine the growing field of epigenetic research. FOXO’s Bioinformatics Services offers a comprehensive platform of advanced data solutions tailored to meet the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
